Drug Type Synthetic peptide |
Synonyms biomimetic peptide (Johns Hopkins University School of Medicine), AXT-120, AXT120 |
Target |
Mechanism VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wet age-related macular degeneration | Preclinical | US | 01 Jul 2018 | |
Wet age-related macular degeneration | Preclinical | US | 01 Jul 2018 | |
Glaucoma, Neovascular | Preclinical | US | - | |
Glaucoma, Neovascular | Preclinical | US | - |